Excited to share our new paper out today in @LeukemiaJnl! CLL cell-derived #exosomes disrupt immune and hematopoietic systems – reprogramming immune cells, suppressing hematopoiesis, and driving disease. Read full article: rdcu.be/eglXM@MDAndersonNews#CLL#leusm
ALT The causes of immune suppression, neutropenia, and anemia in CLL remain unclear. We found that exosomes derived from CLL cells – taken up by healthy monocytes, fibrocytes, and lymphocytes – alter gene/protein expression and suppress normal blood cell formation. These exosomes reprogram monocytes to mimic CLL-supportive cells, upregulate immune checkpoint proteins in T cells, and induce apoptosis and CD5 expression in normal B cells. RNA profiling showed that CLL exosomes carry RNAs promoting apoptosis, metabolism, proliferation, and PI3K–mTOR signaling. They also inhibit hematopoietic progenitor cell growth and impair monocyte-derived fibrocyte support. Our findings suggest CLL exosomes actively disrupt immune and hematopoietic function, contributing to disease progression.
On this cover JAK2 is phosphorylated in tartrate-resistant acid phosphatase/cathepsin K –positive osteoclasts located along sclerotic bone trabecula of a myelofibrosis patient with a JAK2V617F mutation. bloodjournal.org/content/133…
BREAKING NEWS
The 2018 #NobelPrize in Physiology or Medicine has been awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.”